Skip to content

Treat Sirolimus Eluting Coronary Stent System

by Purple MicroPort Cardiovascular Private Limited EUDAMED

Active European Union

Ref CC2.1 4.5013

Regulatory status

as of 27 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDD NumberB-08904121810161 Basic UDI-DIDate23 May 2026RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

European Union — CE/MDD Expiring

Certificates: none listed in EUDAMED

Specification

EUDAMED

Model / Reference
CC2.1 4.5013
Primary DI / UDI-DI
08904121810161
Basic UDI-DI
B-08904121810161
EMDN Code
P070402010301 Coronary drug eluting stents (des) with polymers
Device Class
Class III
Market of Registration
Türkiye

Manufacturer details

EUDAMED SRN
IN-MF-000028173
Authorised representative
Obelis s.a. BE-AR-000000106

Other devices from Purple MicroPort Cardiovascular Private Limited

See all devices from Purple MicroPort Cardiovascular Private Limited →

Properties

  • Sterile
  • Implantable
  • Administering Medicine
  • Incorporates Medicinal Product

Other properties (7)

  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Measuring Function: No